The Claim
The claim is that ordinary exposure to 5G phones, base stations or small cells causes cancer.
That sounds like one question, but “5G exposure” covers different frequencies and geometries: a phone transmitting against the body is not the same exposure as a distant base station, and mid-band 5G is not the same as millimetre-wave 5G.
The useful question is therefore: has real-world 5G exposure been shown to cause cancer, and what can the broader RF evidence legitimately tell us?
Where It Comes From
5G arrived on top of a long-running debate about radiofrequency electromagnetic fields from mobile phones, broadcast systems and Wi-Fi.
It also introduced features that sound novel: new frequency bands, beamforming and denser infrastructure. At the same time, IARC’s existing classification of RF-EMF is Group 2B: possibly carcinogenic to humans, and experimental-animal studies have reported tumours under some RF exposure conditions.
Those facts justify investigation. They do not establish the specific 5G claim.
Why It Sounds Convincing
“Higher frequency” can sound like “more dangerous radiation.” But frequency, photon energy, penetration depth, field strength, duty cycle and absorbed power are separate quantities.
Even millimetre-wave 5G remains non-ionizing; individual photons do not have enough energy to ionize DNA the way X-rays can. At higher RF frequencies, absorption also becomes more superficial.
That rules out one familiar carcinogenic mechanism. It does not prove that every non-ionizing exposure is biologically irrelevant.
The Short Answer
Ordinary 5G exposure has not been shown to cause cancer.
The best human cancer evidence still comes mainly from older RF technologies because 5G deployment is too recent for decades-long latency studies. Those broader human studies have not shown increased risk for the best-studied tumours.
Animal evidence deserves more caution. A corrected 2026 systematic review reports high certainty, under its framework, for two tumour outcomes. A published 2026 commentary disputes that certainty grading and finds much wider statistical uncertainty.
The correct conclusion is therefore not “5G is proven harmless.” It is that the specific causal claim has not been established.
How It Would Have to Work
A meaningful 5G cancer effect should connect realistic exposure to a reproducible carcinogenic process and, eventually, to a human population signal.
That requires well-characterized dose, biologically plausible effects at those doses, and higher cancer incidence among more-exposed populations after appropriate latency and confounder control.
Because widespread 5G deployment began only around 2019, the long-latency part of that chain is still immature.
What Actually Happens
5G is not one frequency
5G is a communications standard, not a single wavelength. Networks can use lower bands, mid-band spectrum around a few gigahertz and, in some deployments, much higher millimetre-wave frequencies.
Claims that “all 5G is 60 GHz” or that every 5G exposure behaves identically are therefore wrong.
Beamforming changes exposure patterns
Antenna arrays can steer energy toward active users. Exposure can vary sharply with traffic, position and whether the user’s own device is uploading or downloading.
A 2025 campaign across more than 800 European microenvironments found environmental exposures below international guideline values in the measured settings, while user-induced uplink exposure could dominate during intensive uploads.
That tells us something about dose. It does not independently prove zero cancer risk.
Direct 5G cancer epidemiology is still young
Cancer studies need time. A lack of 20- or 30-year 5G cohorts is expected because the technology has not existed that long.
That absence creates uncertainty; it is not positive evidence of harm.
What the Evidence Shows
Broader human RF evidence
The 2024 systematic review of human observational RF studies did not find increased risk for several of the best-studied tumours associated with mobile-phone exposure. Evidence for fixed-site transmitters was more limited.
These studies matter because they test RF exposure in people. They are not perfect substitutes for 5G because frequencies, modulation and exposure patterns differ.
Animal evidence
The corrected animal review reports high-certainty evidence under its framework for increased heart schwannomas and glial-cell tumours.
A 2026 methodological commentary argues that the review did not adequately integrate all studies and departed from its planned quantitative approach. Its alternative analysis produced wide confidence intervals; the glioma estimate included no effect, while the cardiac-schwannoma estimate remained elevated but imprecise.
The disagreement is about the strength of inference, not whether positive animal findings exist.
Animal exposures also differ from everyday 5G in dose, geometry, duration and species. Translating them into a human risk estimate is a separate step.
Above-6-GHz evidence
The direct evidence base for low-level exposure above 6 GHz is smaller. A 2021 review found little replicated evidence of health effects but substantial study-quality limitations; a later published comment challenged parts of that review.
The reasonable conclusion is incomplete evidence, not proof in either direction.
The Strongest Evidence for the Claim
The strongest case for concern is the combination of IARC’s Group 2B classification, tumour findings in animals, uncertainty over how strongly those animal findings should be graded, and the absence of decades-long 5G-specific human follow-up.
Those points justify surveillance and better studies. They do not demonstrate cancer from ordinary 5G use or nearby infrastructure.
The Strongest Evidence Against It
The strongest counter-evidence is the lack of a reproducible human cancer signal in the broader RF literature together with measured real-world 5G exposures that are generally low relative to established limits.
The mechanism also matters: 5G RF does not directly ionize DNA. Any carcinogenic pathway would have to operate through a different mechanism and be shown at realistic absorbed doses.
Common Viral Arguments
“5G uses higher frequencies, so it must be more dangerous.”
Higher frequency changes wavelength, penetration and absorption. Risk also depends on power, duration, geometry and absorbed dose.
“There are no long-term 5G studies.”
Correct. That is a limitation of a recent technology, not evidence that cancer is occurring.
“IARC says RF is carcinogenic.”
IARC’s current category is possibly carcinogenic to humans (Group 2B). It is a hazard classification, not a numerical risk estimate for a 5G phone or tower.
“Animal studies prove 5G causes tumours.”
They are broader RF experiments under specific laboratory exposures, not direct ordinary-5G studies in people. Their evidentiary strength is also methodologically disputed.
“Below the legal limit means safe.”
Compliance is useful exposure context. It is not independent proof of zero risk.
The Reasoning Error
The main error is hazard-risk confusion: evidence that RF can cause harm under some condition is treated as though it directly quantifies risk from a specific 5G exposure.
A second is dose neglect, which treats a laboratory whole-body exposure, a phone against the body and a distant antenna as interchangeable.
A third is the category error of importing the mechanisms of ionizing radiation into non-ionizing RF without demonstrating the same causal pathway.
What Would Change Our Conclusion?
The conclusion would change if well-designed human studies with measured 5G exposure found a reproducible cancer increase with appropriate latency and dose-response characteristics.
Replicated animal and mechanistic effects at exposure patterns closely matching ordinary 5G would also strengthen the case. Strong long-term 5G-specific cohorts with consistently null results would increase confidence in the opposite direction.
Evidence Status
Unsupported. The available evidence does not demonstrate that ordinary 5G exposure causes cancer. Broader RF research contains genuine hazard signals and unresolved questions, but those do not establish the specific real-world 5G claim.
Sources
The evidence trail includes WHO/IARC material, human RF cancer systematic reviews, the corrected animal review and its published methodological critique, above-6-GHz research and direct measurements of modern 5G exposure.
Corrections & Updates
No corrections recorded.
Last Reviewed
September 30, 2026.